Engineered for high biological availability, skin barrier recovery, and clinical-grade dermaceutical markets. Select a product profile or download our full formula catalog.
Understanding therapeutic concentration gradients, crystal stability, and pH stabilization in high-efficiency manufacturing.
Urea (Carbamide) remains one of the gold-standard active humectants and keratolytic agents in medical-grade personal care. As an integral component of the skin's Natural Moisturizing Factor (NMF), topical urea plays a dual role: at physiological concentrations (≤10%), it acts as a hygroscopic humectant enhancing stratum corneum hydration; at therapeutic concentrations (20% to 42%), it breaks down hydrogen bonds in hyperkeratotic proteins, promoting controlled, gentle desquamation. However, industrial production of high-percentage urea body lotions presents significant biochemical challenges, notably ambient degradation into ammonia and carbon dioxide, resulting in pH drift, phase destabilization, and scent degradation.
As China's premier specialized manufacturer and international exporter of cosmetic emulsions, our facility integrates Tri-Buffered Stabilization Mechanisms and multi-phase shear homogenization. By introducing targeted lactic acid/sodium lactate buffers alongside biomimetic lipid carriers (Ceramides NP/AP/EOP and Phytosphingosine), we secure thermodynamic suspension stability across extreme transport temperatures, providing brands worldwide with export-ready solutions that maintain rheological consistency over a documented 36-month shelf life.
| Target Concentration | Primary Bio-Mechanism | Clinical Target & Indication | Carrier Base & Auxiliary Actives | Export Compliance |
|---|---|---|---|---|
| 5% - 10% Urea | Hydrophilic Water-Binding | Daily Xerosis, Atopic-Prone Skin, Winter Dehydration | Hyaluronic Acid (Multi-weight), Squalane, Shea Esters | Global OTC / Cosmetics Grade |
| 15% - 20% Urea | Micro-Exfoliation & Softening | Keratosis Pilaris (KP), Rough Elbows & Knees, Follicular Plugging | Salicylic Acid (BHA), Ceramide Complex, Centella Extract | EU Regulation (EC) 1223/2009 |
| 30% - 40%+ Urea | High-Strength Keratolytic | Severe Hyperkeratosis, Cracked Heel Fissures, Calluses | Lactic Acid, Dimethicone Emollient Barrier, Allantoin | FDA Monograph / Medical Device |
Urea readily degrades in aqueous systems when subject to heat. Our proprietary tri-acid balance guarantees zero ammonia odor formation and retains strict pH bounds between 5.5 and 6.2 throughout transit.
Utilizing high-shear vacuum emulsification technology imported from Germany, active particulates are refined to under 0.8 microns, eliminating grittiness and crystallization common in inferior formulations.
Rather than relying purely on occlusive mineral barriers, we integrate physiological lipid matrices (cholesterol, ceramides, and bio-identical fatty acids) to repair the epidermal structure long after rinse-off.
Data-driven insights for procurement officers, enterprise brand managers, and B2B sourcing networks.
Consumer expectations have transitioned from basic hydration to targeted body problem solving. Demand for urea formulations spiked 34% year-over-year in North America and Western Europe, primarily driven by solutions addressing "Strawberry Legs", keratosis pilaris, and aging skin turnover.
Regulatory frameworks such as the EU Cosmetics Regulation (EC) No 1223/2009 and the US MoCRA mandate rigorous trace-impurity assessments and full CPSR dossiers. Buyers are migrating production toward facilities that provide pre-validated clinical testing, preservative efficacy testing (PET), and batch heavy-metal chromatography.
Large retail contracts (Target, Boots, Sephora Clean) now necessitate non-airless pump compatibility for thick 20% urea bases while transitioning to minimum 30% to 100% PCR HDPE/PET packaging. Our industrial supply chain maintains verified compatibility pipelines with leading global packaging suppliers.
Our intelligent digital factory delivers high-capacity throughput, rapid tech transfer, and international quality governance.
Operating Class 100,000 cleanroom workshops equipped with micro-filtered HVAC air treatment, computerized water purification (EDI + Two-Stage Reverse Osmosis), and automated pipeline sterilization systems.
We supply comprehensive documentation required by cross-border customs and health authorities: Certificate of Free Sale (CFS), MSDS, COA, Formula Breakdown Declarations, IFRA Fragrance Compliance, and GMP Audit Certificates.
Whether deploying low-risk testing runs for digital-first indie brands or manufacturing containerized bulk shipments for multinational retail supply, our production lines scale effortlessly from 1,000 units to multi-million SKU portfolios.
Clear, direct technical and commercial answers designed for global brand directors and procurement departments.
Crystallization and viscosity breakdown occur when urea recrystallizes out of solution due to inadequate solvent matrix balance or fluctuating thermal environments. We overcome this using a co-solvent polyol complex combined with polymeric cross-linked stabilizers (such as Ammonium Acryloyldimethyltaurate/VP Copolymer) and optimized non-ionic emulsifiers. This network holds the urea molecules inside microscopic micellar droplets, guaranteeing thermal stability from -10°C to 48°C during overseas shipping.
For pre-tested, clinically validated stock formulas (such as 10% Urea Daily Hydration or 20% Urea + 2% Salicylic Acid KP Cream), MOQs start as low as 1,000 units with our standard in-house packaging. For fully customized formulas requiring unique active complexes, bespoke fragrances, or custom tooling molds, our standard MOQ is typically 5,000 to 10,000 units per SKU depending on packaging component requirements.
Yes. All of our raw materials are vetted against European SCCS bans and restrictions. We strictly monitor trace impurities (such as biuret and heavy metals) and ensure preservative efficacy through 28-day challenge testing (ISO 11930). We provide complete raw material dossiers, INCI lists, stability challenge reports, and manufacturing process summaries directly to your appointed Responsible Person (RP) or regulatory consultant.
Standard benchmark timing: Sample formulation and benchtop prototyping takes 5-7 working days. Following prototype sign-off, accelerated 30-day stability and compatibility verification begins. Packaging printing and raw material consolidation takes approximately 20 days. Bulk production, filling, boxing, and final quality release is completed in 10-15 business days. Re-orders with identical artwork typically dispatch within 14-21 days.
Every single batch undergoes stringent internal Quality Control (QC) prior to filling: assay of urea content (spectrophotometric verification), dynamic viscosity index (Brookfield Viscometer), specific gravity, pH value (calibrated at 25°C), microbiological enumeration (Total Aerobic Microbial Count <100 CFU/g, zero pathogens), and centrifuge stability testing (3000 rpm for 30 minutes with zero separation).
Request turnkey formula benchmarks, clinical stability datasets, packaging catalog, or initiate custom lab prototyping with our lead cosmetic chemists.
